Tonix Pharmaceuticals Holding Corp. (TNXP)

NMS – Real Time Price. Currency in USD

12.00

-0.34 (-2.76%)

At close: Aug 12, 2026, 3:59 PM EDT

12.00

+0.03 (0.25%)

After-hours: Aug 12, 2026, 5:35 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

13M

10M

Cost of goods sold

-9M

-11M

-9M

-1M

Gross Profit

-1M

Operating expenses (excl. COGS)

-130M

-77M

-117M

-111M

Operating Income

-126M

-78M

-118M

-112M

Non-operating income, total

-52M

Pretax income

-124M

-130M

-117M

-110M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-124M

-130M

-117M

-110M

Discontinued operations

Net income

-124M

-130M

-117M

-110M

Dilution adjustment

Preferred dividends

Tonix Pharmaceuticals Holding Corp. (TNXP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Tonix Pharmaceuticals Holding Corp. (TNXP)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Tonix Pharmaceuticals Holding Corp. (TNXP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Tonix Pharmaceuticals Holding Corp. (TNXP)

Income Statement (Annual)

Income Statement (Annual)